Summary Serendex Pharmaceuticals A/S (Serendex) is a drug development company that develops drugs for the treatment of respiratory conditions by inhalation. The company concentrates on securing new treatment for patients with life threatening lung diseases. Its products are used in the treatment of pulmonary alveolar proteinosis, cystic fibrosis related lung infections, bronchiectasis, ventilator-associated pneumonia, blast lung injury and diffuse alveolar hemorrhage, among others. The company partners and collaborates with other pharma and drug development companies across the world to develop its products. Serendex is headquartered in Horsholm, Denmark. Serendex Pharmaceuticals AS (SENDEX) Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from... Research Beam Model: Research Beam Product ID: 663121 250 USD New
Serendex Pharmaceuticals AS (SENDEX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Serendex Pharmaceuticals AS (SENDEX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Company Profiles
  • Published On : May   2016
  • Pages : 20
  • Publisher : GlobalData
 
 
 
Summary

Serendex Pharmaceuticals A/S (Serendex) is a drug development company that develops drugs for the treatment of respiratory conditions by inhalation. The company concentrates on securing new treatment for patients with life threatening lung diseases. Its products are used in the treatment of pulmonary alveolar proteinosis, cystic fibrosis related lung infections, bronchiectasis, ventilator-associated pneumonia, blast lung injury and diffuse alveolar hemorrhage, among others. The company partners and collaborates with other pharma and drug development companies across the world to develop its products. Serendex is headquartered in Horsholm, Denmark.

Serendex Pharmaceuticals AS (SENDEX) Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Serendex Pharmaceuticals A/S, Medical Devices Deals, 2010 to YTD 2016 9
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 11
Licensing Agreements 12
Serendex Pharma Enters into Licensing Agreement with Japan based Pharma Company 12
Equity Offering 13
Serendex Pharma Raises USD12.7 Million Rights Offering of Shares 13
Serendex Pharma Completes IPO for USD11 Million 15
Serendex Pharmaceuticals A/S - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables
List of Tables
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Key Facts, 2014 1
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Serendex Pharmaceuticals A/S, Deals By Therapy Area, 2010 to YTD 2016 8
Serendex Pharmaceuticals A/S, Medical Devices Deals, 2010 to YTD 2016 9
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 11
Serendex Pharma Enters into Licensing Agreement with Japan based Pharma Company 12
Serendex Pharma Raises USD12.7 Million Rights Offering of Shares 13
Serendex Pharma Completes IPO for USD11 Million 15
Serendex Pharmaceuticals A/S, Key Competitors 17
Serendex Pharmaceuticals A/S, Key Employees 18
Serendex Pharmaceuticals A/S, Subsidiaries 19

List Of Figures
List of Figures
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Serendex Pharmaceuticals A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Serendex Pharmaceuticals A/S, Medical Devices Deals, 2010 to YTD 2016 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter